Skip to content

A prospective cohort study of the characteristics of the pre-asthma population and the evolution of the disease integrating elements of traditional Chinese and Western medicine

A prospective cohort study of the characteristics of the pre-asthma population and the evolution of the disease integrating elements of traditional Chinese and Western medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025000362
Enrollment
Unknown
Registered
2025-02-19
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-asthma

Interventions

Pre-asthma:None
Mild asthma:None

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Pre-asthma (1) Age= 18 years old male or female; (2) meet the diagnostic criteria for pre-asthma; (3) The patient is informed and signs the informed consent form. Mild asthma: (1) Age= 18 years old male or female; (2) meet the diagnostic criteria for mild; (3) The patient is informed and signs the informed consent form. Healthy Volunteers: (1) Age= 18 years old male or female; (2) No obvious abnormalities were found in the physical examination in the past year; (3) The patient is informed and signs the informed consent form.

Exclusion criteria

Exclusion criteria: Pre-asthma (1) Previous diagnosis of asthma; (2) Combined with chronic obstructive pulmonary disease bronchiectasis interstitial lung disease obstructive sleep apnea syndrome pulmonary malignancy active tuberculosis and other diseases; (3) Acute upper respiratory tract infection or pneumonia has been found in the past 1 month; (4) Severe cardiovascular and cerebrovascular diseases (including malignant arrhythmia acute myocardial infarction cardiac function grade 4 acute stroke etc.) and hematological diseases; (5) Combined with severe liver and kidney diseases including decompensated liver cirrhosis hemorrhage caused by portal hypertension or portal varices renal dialysis etc.; (6) Combined immunodeficiency such as malignant tumors organ/bone marrow transplantation HIV infection; (7) Those with mental disorders or cognitive disabilities. Mild asthma: (1) Combined with chronic obstructive pulmonary disease bronchiectasis interstitial lung disease obstructive sleep apnea syndrome pulmonary malignancy active tuberculosis and other diseases; (2) Severe cardiovascular and cerebrovascular diseases (including malignant arrhythmia acute myocardial infarction grade 4 cardiac function acute stroke etc.) and hematological diseases; (3) Combined with severe liver and kidney diseases including decompensated liver cirrhosis hemorrhage caused by portal hypertension or portal varices renal dialysis etc.; (4) Immunodeficiency such as malignant tumors organ/bone marrow transplantation HIV infection; (5) Those with mental disorders or cognitive disabilities. Healthy Volunteers: (1) Previous diagnosis of asthma; (2) Combined with chronic obstructive pulmonary disease bronchiectasis interstitial lung disease obstructive sleep apnea syndrome pulmonary malignancy active tuberculosis and other diseases; (3) Patients with allergic rhinitis eczema urticaria atopic dermatitis allergic conjunctivitis and other allergic diseases; (4) History of drug or food allergies in the past; (5) Acute upper respiratory tract infection or pneumonia has been found in the past 1 month; (6) Those with a history of smoking or lung-related surgeries; (7) Patients with serious primary diseases or malignant tumors of other organs (such as heart brain liver kidney etc.); (8) Patients with immune-related diseases such as systemic lupus erythematosus Sjögren's syndrome rheumatoid arthritis etc.; (9) Those with mental disorders or cognitive disabilities;

Design outcomes

Primary

MeasureTime frame
Asthma incidence;

Secondary

MeasureTime frame
Distribution and changes of TCM syndromes;Annual rate of decline in peak and trough values of FEV1 and FVC in lung function;Change in FeNO value;Negative rate of bronchial dilation test;Demographic characteristics of patients with pre-asthma;Positive rate of bronchial dilation test;The distribution and change of TCM constitution assessment;Negative rate of bronchial provocation test;Incidence of exacerbations;Positive rate of bronchial provocation test;Valleys and peak changes of FEV1 FVC FEV1/FVC MMEF FEF50 FEF75;Change in Cough Degree Score (CET).;Distribution and change of TCM wet syndrome points;Asthma control scores including changes in ACT and ACQ;

Countries

China

Contacts

Public ContactYuanbin Chen

Guangdong Provincial Hospital of Chinese Medicine

chenyuanbin110@163.com15920174645

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026